654 related articles for article (PubMed ID: 12161539)
21. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation.
Cullinan EB; Abbondanzo SJ; Anderson PS; Pollard JW; Lessey BA; Stewart CL
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3115-20. PubMed ID: 8610178
[TBL] [Abstract][Full Text] [Related]
22. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
Kovacs E; Kuehn JJ
Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
[TBL] [Abstract][Full Text] [Related]
23. Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.
Ito Y; Yamamoto M; Mitsuma N; Li M; Hattori N; Sobue G
Neurochem Res; 2001 Jan; 26(1):51-8. PubMed ID: 11358282
[TBL] [Abstract][Full Text] [Related]
24. Profile of soluble cytokine receptors in Crohn's disease.
Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
[TBL] [Abstract][Full Text] [Related]
25. Immunolocalisation of phosphorylated STAT3, interleukin 11 and leukaemia inhibitory factor in endometrium of women with unexplained infertility during the implantation window.
Dimitriadis E; Sharkey AM; Tan YL; Salamonsen LA; Sherwin JR
Reprod Biol Endocrinol; 2007 Nov; 5():44. PubMed ID: 18047677
[TBL] [Abstract][Full Text] [Related]
26. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
27. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit.
Modrell B; Liu J; Miller H; Shoyab M
Growth Factors; 1994; 11(2):81-91. PubMed ID: 7857660
[TBL] [Abstract][Full Text] [Related]
28. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
29. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
30. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.
Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T
Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350
[TBL] [Abstract][Full Text] [Related]
31. Regulation of signal transducer, GP13O and the LIF receptor in acute inflammation in vivo.
Geisterfer M; Gauldie J
Cytokine; 1996 Apr; 8(4):283-7. PubMed ID: 9162216
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma.
Zhang JG; Zhang Y; Owczarek CM; Ward LD; Moritz RL; Simpson RJ; Yasukawa K; Nicola NA
J Biol Chem; 1998 Apr; 273(17):10798-805. PubMed ID: 9553147
[TBL] [Abstract][Full Text] [Related]
33. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.
Shimon I; Yan X; Ray DW; Melmed S
J Clin Invest; 1997 Jul; 100(2):357-63. PubMed ID: 9218512
[TBL] [Abstract][Full Text] [Related]
34. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves.
Ito Y; Yamamoto M; Li M; Doyu M; Tanaka F; Mutch T; Mitsuma T; Sobue G
Brain Res; 1998 May; 793(1-2):321-7. PubMed ID: 9630704
[TBL] [Abstract][Full Text] [Related]
35. Cytokine pleiotropy and redundancy--gp130 cytokines in human implantation.
Sánchez-Cuenca J; Martín JC; Pellicer A; Simón C
Immunol Today; 1999 Feb; 20(2):57-9. PubMed ID: 10098321
[No Abstract] [Full Text] [Related]
36. Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.
Takagi M; Nakamura T; Sawada T; Kaneko A; Nozaki-Ukai M; Nakahata T; Yokota T; Heike T
Mol Biol Cell; 1999 Nov; 10(11):3633-42. PubMed ID: 10564261
[TBL] [Abstract][Full Text] [Related]
37. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window.
Tabibzadeh S; Kong QF; Babaknia A; May LT
Hum Reprod; 1995 Oct; 10(10):2793-9. PubMed ID: 8567815
[TBL] [Abstract][Full Text] [Related]
38. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways.
Yoshida K; Chambers I; Nichols J; Smith A; Saito M; Yasukawa K; Shoyab M; Taga T; Kishimoto T
Mech Dev; 1994 Feb; 45(2):163-71. PubMed ID: 8199053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
